Synthesis and biological evaluation of Bis-2-(1,3,8-triazaspiro[4,5]decan-4-one)ethylamine based radiopharmaceuticals for neuroendocrine tumor

被引：0
|
作者：
Sethi, S. K. [1 ]
Varshney, R. [1 ]
Hazari, P. P. [1 ]
Milton, M. D. [2 ]
Mishra, A. K. [1 ]
机构：
[1] Inst Nucl Med & Allied Sci, Delhi, India
[2] Univ Delhi, Delhi 110007, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2011年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 50 条
  • [1] 8-[(4-METHYLPHENYL)METHYL]-1-PHENYL-1,3,8-TRIAZASPIRO[4,5]DECAN-4-ONE
    HUMBLET, C
    DURANT, F
    EVRARD, G
    KOCH, MHJ
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1976, 32 (OCT15): : 2878 - 2880
  • [2] Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4,5]decan-4-one ring system
    Mavunkel, BJ
    Lu, ZJ
    Goehring, RR
    Lu, SF
    Chakravarty, S
    Perumattam, J
    Novotny, EA
    Connolly, M
    Valentine, H
    Kyle, DJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) : 3169 - 3173
  • [3] Design, synthesis and biological evaluation of mu opioid selective biaryl-substituted 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one derivatives
    Jordan, AD
    Orsini, MJ
    Middleton, SA
    Connolly, PJ
    Brenneman, DE
    Pan, K
    Reitz, AB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2570 - U2570
  • [4] Design, synthesis and biological evaluation of 2-arylaminopyrimidine derivatives bearing 1,3,8-triazaspiro[4,5]decan-4-one or piperidine-3-carboxamide moiety as novel Type-I1/2 ALK inhibitors
    Miao, Xiuqi
    Xing, Lingyun
    Guo, Ming
    Zhang, Hong
    Liu, Sicong
    Yin, Shiliang
    Gong, Ping
    Zhang, Dajun
    Zhai, Xin
    BIOORGANIC CHEMISTRY, 2020, 94
  • [5] ELECTRON-IMPACT MASS-SPECTROMETRY OF SUBSTITUTED 1,3,8-TRIAZASPIRO[4,5]DECAN-4-ONES
    DANIELI, B
    RUBINO, FM
    ZECCA, L
    BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1989, 18 (11): : 1000 - 1004
  • [6] Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity
    Lavieri, Robert
    Scott, Sarah A.
    Lewis, Jana A.
    Selvy, Paige E.
    Armstrong, Michelle D.
    Brown, H. Alex
    Lindsley, Craig W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2240 - 2243
  • [7] Preparation of 8-[3-(4-fluorobenzoyl)-propyl]-1-(4-[I-123]iodobenzoyl)-1,3,8-triazaspiro[4,5]decan-4-one: A novel selective serotonin 5-HT2 receptor agent
    Samnick, S
    Brandau, W
    Nolken, G
    Gerhards, HJ
    Schober, O
    NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (04) : 295 - 303
  • [8] Preparation of 8-[3-(4-fluorobenzoyl)-propyl]-1-(4-[I-123/125]-iodobenzoyl)-1,3,8-triazaspiro[4,5]decan-4-one:: A novel selective serotonin 5-HT2 receptor agent.
    Brandau, W
    Samnick, S
    Dutschka, K
    Schober, O
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 226P - 226P
  • [9] 1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity
    Guillon, Jean
    Savrimoutou, Solene
    Rubio, Sandra
    Moreau, Stephane
    Pinaud, Noel
    Marchivie, Mathieu
    Desplat, Vanessa
    MOLBANK, 2020, 2020 (01)
  • [10] CRYSTAL AND MOLECULAR-STRUCTURE OF 8-[3-(PARA-FLUOROBENZOYL)PROPYL]-1-PHENYL-1,3,8-TRIAZASPIRO[4,5]DECAN-4-ONE, C23H26N3O2F
    KOCH, MHJ
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1973, B 29 (MAR15): : 379 - 382
12345